-
Review
April 15, 2022
- Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
- Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, et al.
- Clin Mol Hepatol. 2023;29(1):1-15.
- Review
- Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
- Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller
- Clin Mol Hepatol. 2023;29(1):1-15. Published online April 15, 2022
-
View: 5536 Download: 86

- Management of refractory ascites
- Florence Wong
- Clin Mol Hepatol. 2023;29(1):16-32. Published online June 9, 2022
-
View: 1772 Download: 322

- Wnt signaling in liver regeneration, disease, and cancer
- Gengyi Zou, Jae-Il Park
- Clin Mol Hepatol. 2023;29(1):33-50. Published online July 4, 2022
-
View: 1582 Download: 128

- Development and prognosis of hepatocellular carcinoma in patients with diabetes
- Takuma Nakatsuka, Ryosuke Tateishi
- Clin Mol Hepatol. 2023;29(1):51-64. Published online July 29, 2022
-
View: 1341 Download: 131 Citations: 2

- Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
- Soo-Jeung Park, Young S. Hahn
- Clin Mol Hepatol. 2023;29(1):65-76. Published online August 12, 2022
-
View: 1440 Download: 103 Citations: 2

- Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
- Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
- Clin Mol Hepatol. 2023;29(1):77-98. Published online October 13, 2022
-
View: 1581 Download: 266

- Editorial
- The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(1):99-101. Published online October 27, 2022
-
View: 602 Download: 31
- The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
- Jeong-Ju Yoo, Sang Gyune Kim
- Clin Mol Hepatol. 2023;29(1):102-104. Published online November 10, 2022
-
View: 552 Download: 69
- Non-invasive tests-based risk stratification: Baveno VII and beyond
- Georg Semmler, Mathias Jachs, Mattias Mandorfer
- Clin Mol Hepatol. 2023;29(1):105-109. Published online November 23, 2022
-
View: 586 Download: 45 Citation: 1

- Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
- Susana G Rodrigues
- Clin Mol Hepatol. 2023;29(1):110-112. Published online December 12, 2022
-
View: 514 Download: 36
- Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
- Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
- Clin Mol Hepatol. 2023;29(1):113-117. Published online October 31, 2022
-
View: 638 Download: 45 Citation: 1
- New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
- Young-Suk Lim
- Clin Mol Hepatol. 2023;29(1):118-119. Published online November 29, 2022
-
View: 418 Download: 56
- Original Article
- Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
- Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2023;29(1):120-134. Published online August 12, 2022
-
View: 1039 Download: 97 Citations: 2

- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
- Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
- Clin Mol Hepatol. 2023;29(1):135-145. Published online September 5, 2022
-
View: 1459 Download: 181 Citations: 4

- Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
- Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(1):146-162. Published online August 19, 2022
-
View: 1123 Download: 144 Citations: 3

- Letter to the Editor
- Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Yuanbin Liu, Mingkai Chen
- Clin Mol Hepatol. 2023;29(1):163-164. Published online October 27, 2022
-
View: 611 Download: 36
- Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Do Seon Song, U Im Chang, Jin Mo Yang
- Clin Mol Hepatol. 2023;29(1):165-167. Published online October 31, 2022
-
View: 661 Download: 37 Citation: 1
- Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
- Clin Mol Hepatol. 2023;29(1):168. Published online October 31, 2022
-
View: 731 Download: 39 Citation: 1
- Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
- Hye Won Lee
- Clin Mol Hepatol. 2023;29(1):169-170. Published online November 10, 2022
-
View: 546 Download: 24 Citation: 1
- Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Seung Min Lee, Dae Won Jun
- Clin Mol Hepatol. 2023;29(1):171-172. Published online November 10, 2022
-
View: 442 Download: 27
- Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
- Clin Mol Hepatol. 2023;29(1):173-175. Published online November 15, 2022
-
View: 418 Download: 21
- Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2023;29(1):176-178. Published online November 10, 2022
-
View: 494 Download: 33
- Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
- Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
- Clin Mol Hepatol. 2023;29(1):179-181. Published online November 22, 2022
-
View: 402 Download: 24
- Correspondence
- Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
- Won Sohn, Yong-Han Paik
- Clin Mol Hepatol. 2023;29(1):182-184. Published online November 22, 2022
-
View: 458 Download: 23
- Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
- Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
- Clin Mol Hepatol. 2023;29(1):185-187. Published online November 10, 2022
-
View: 420 Download: 15
- Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
- Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
- Clin Mol Hepatol. 2023;29(1):188-190. Published online November 22, 2022
-
View: 498 Download: 31
- Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
- Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(1):191-193. Published online November 22, 2022
-
View: 397 Download: 29
- Snapshot
- Epidemiology and updated management for autoimmune liver disease
- Nae-Yun Heo, Haeryoung Kim
- Clin Mol Hepatol. 2023;29(1):194-196. Published online December 14, 2022
-
View: 518 Download: 41
